GIANNOTTA, CLAUDIA
GIANNOTTA, CLAUDIA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status
2022-01-01 Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA
2022-01-01 C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia.
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT
2020-01-01 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS
2018-01-01 B Castella, C Riganti, M Foglietta, E Tripoli, C Giannotta, M Massaia
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
2023-01-01 Giannotta, Claudia; Autino, Federica; Massaia, Massimo
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
2023-01-01 Giannotta, Claudia; Autino, Federica; Massaia, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status | 2022 | Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo | |
| IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA | 2022 | C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia. | |
| MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT | 2020 | B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia. | |
| MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS | 2018 | B Castella, C Riganti, M Foglietta, E Tripoli, C Giannotta, M Massaia | |
| The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells | 2023 | Giannotta, Claudia; Autino, Federica; Massaia, Massimo | |
| Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? | 2023 | Giannotta, Claudia; Autino, Federica; Massaia, Massimo |